Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

Fan Yi Meng, MD, Ling Jiang, MD PhD, Qingxiu Zhong, MD, Li Chun Wang, MD, Guopan Yu, MD, Xinhua Zhu, MD

Blood (2014) 124 (21): 5953.

https://doi.org/10.1182/blood.V124.21.5953.5953

Published: 2014

Journal Articles

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.

Yang Shen, MD, Zhixiang Shen, MD, Bin Jiang, MD, Jian Hou, MD, Rong Zhan, MD, Lugui Qiu, MD, Yongji Wu, MD, Jie Jin, MD, Juan Li, MD, Fanyi Meng, MD, Ping Zou, MD, Ting Liu, MD, Jianyong Li, MD, Chun Wang, MD, Depai Wu, MD, Jun Ma, MD

Blood (2007) 110 (11): 4816.

https://doi.org/10.1182/blood.V110.11.4816.4816

Published: 2007

Journal Articles

Adjustment of Immonosuppressants Based on T Lymphocyte Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation.

Chun Wang, MD, Liping Wan, MD, Shike Yan, MD, Jieling Jiang, MD, Jun Yang, MD, Youwen Qin, MD

Blood (2006) 108 (11): 5284.

https://doi.org/10.1182/blood.V108.11.5284.5284

Published: 2006

Journal Articles

Treatment of Hematological Malignancies in Central Nervous System with Idarubicin and Teniposide Containing Regimens.

Chun Wang, MD, PhD, Xiaojun He, MD, Qi Cai, MD, Jun Zhu, MD, Haitao Bai, MD

Blood (2005) 106 (11): 4731.

https://doi.org/10.1182/blood.V106.11.4731.4731

Published: 2005

Journal Articles

Inhibitory Effect of RNAi on Expression of bcr/abl Oncogene in K562 Cells.

Chun Wang, MD, PhD, Xiaoxia Ma, MD, Ju Wei, MD, Youwen Qin, MD, Shike Yan, MD

Blood (2005) 106 (11): 4850.

https://doi.org/10.1182/blood.V106.11.4850.4850

Published: 2005

NARROW

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.

Adjustment of Immonosuppressants Based on T Lymphocyte Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation.

Treatment of Hematological Malignancies in Central Nervous System with Idarubicin and Teniposide Containing Regimens.

Inhibitory Effect of RNAi on Expression of bcr/abl Oncogene in K562 Cells.

Email alerts

ASH Publications

American Society of Hematology

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.

Adjustment of Immonosuppressants Based on T Lymphocyte Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation.

Treatment of Hematological Malignancies in Central Nervous System with Idarubicin and Teniposide Containing Regimens.

Inhibitory Effect of RNAi on Expression of bcr/abl Oncogene in K562 Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only